undamentalytics Newsletter

Lifemd, Inc. valuation and forecast

Explore the models for Lifemd, Inc., adjust their assumptions and compare your own valuation with the platform's.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: data-quality checks not passed.

Price vs value

Under review: data-quality checks not passed. We'll show the comparison once resolved.

Analyst recommendations

8 analysts, Oct 2026
Buy8100%
Hold00%
Sell00%

Monthly trend

  1. Oct 202688
  2. Sep 202688
  3. Aug 202688
  4. Jul 202688

Counts of recommendations published by analysts covering Lifemd, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Price history

Loading chart…

Third-party market data · may be delayed

LFMD valuation questions

How does Fundamentalytics value Lifemd, Inc.?
We use the models that fit Lifemd, Inc.'s business and available financial data: revenue-to-maturity model, price-to-sales vs peers. Each model has its own assumptions and data requirements. The calculator explains which models are available and lets you adjust their inputs.

Data: SEC EDGAR filings, retrieved October 29, 2026. Method: how we value companies. Disclosures: research and recommendations disclosure. Back to Lifemd, Inc.

Compare with peers